Annovis Bio Inc — Quarterly Financial Statistics (NYSE:ANVS)

Financials

Cash from operating activities -3.2 M-8.29 M-8.1 M-5.11 M-3.49 M -24.98 M Cash from investing activities ————— — Cash from financing activities 11.84 M6.2 M19.78 M01.64 M 27.63 M Free cash flow -3.2 M-8.29 M-8.1 M-5.11 M-3.49 M -24.98 M

ニュース

アノビス・バイオ、2026年1月にパーキンソン病薬の長期研究を開始へ

Annovis Bio to launch long-term Parkinson’s drug study in January

Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook

Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops

アノビス・バイオの取締役ホフマン氏、19万3,794ドル相当の株式を購入

Annovis Bio director Hoffman buys $193,794 in shares

Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling

アノビス・バイオの取締役ホフマン氏、ANVS株を6万9900ドル分購入

Annovis Bio director Hoffman buys $69.9k in ANVS stock

Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)

Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion

Annovis Bio raises $3.4 million in registered direct offering